EX-101 (Excelmab)

N/A

Report date: 2026/03/19 16:53:29

Base Information

Drug NameEX-101 (Excelmab)

Drug Alias Nameanti-CD3/anti-HER2 bispecific T-cell engager (ExcelMab)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsReceptor protein-tyrosine kinase erbB-2 modulatorsImmunostimulants +[4]

TargetsT cell surface glycoprotein CD3Receptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsSolid tumoursStomach NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesExcelMab Inc

China Registration ClassN/A

Develop Information

Active CompaniesExcelMab Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursStomach NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A